Barclays Maintains Overweight on CVS Health, Raises Price Target to $79

Barclays maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $75 to $79.

Benzinga · 11/07/2019 17:15

Barclays maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $75 to $79.